Using advanced MRI techniques to improve breast cancer treatment.
Quantitative magnetic resonance imaging for non-invasive breast cancer therapy using physics-informed neural networks.
This study is working on improving breast cancer treatment by using new MRI techniques that combine advanced technology and machine learning, so patients can get clearer images of how well their treatments are working, leading to better care and outcomes.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10997959 on NIH RePORTER |
What this research studies
This research aims to enhance breast cancer therapy by developing advanced magnetic resonance imaging (MRI) techniques that utilize machine learning. By integrating physics knowledge into deep learning models, the project seeks to create reliable quantitative MRI methods that can evaluate the effectiveness of MR-guided focused ultrasound treatments for breast cancer. Patients will benefit from improved imaging techniques that provide more accurate assessments of their treatment progress, ultimately leading to better outcomes. The research addresses existing challenges in MRI technology, such as the need for large datasets and variability across imaging protocols.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with breast cancer who are undergoing or considering MR-guided focused ultrasound therapy.
Not a fit: Patients with breast cancer who are not eligible for MR-guided focused ultrasound treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized breast cancer treatments through improved imaging techniques.
How similar studies have performed: Other research has shown promise in using machine learning for medical imaging, indicating that this approach could lead to significant advancements in breast cancer treatment.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Adams, Samuel Ian — University of Utah
- Study coordinator: Adams, Samuel Ian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.